SierraSil Joint Formula 14 as an Ergogenic Aid to Performance in Athletes

N/ACompletedNCT01932281

University of British Columbia10 enrolled

Overview

The purpose of this study is to examine whether supplementation with SierraSil can improve anaerobic power and reduce muscle fatigue in a group of well-trained athletes. A secondary purpose is to examine the effect of SierraSil on the severity of delayed onset muscle soreness.

This is a double blind, crossover, pilot study that will examine the effect of SierraSil supplementation on the determinants of human performance. Anaerobic capacity, muscle fatigue, the severity of delayed onset muscle soreness (DOMS) and markers of inflammation will be measured before and after 3 weeks of supplementation with SierraSil or placebo. There will be a 3 week washout period prior to the crossover to ensure SierraSil supplementation has no residual effect.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Muscle Power Muscle Fatigue

Interventions

SierraSilDIETARY_SUPPLEMENT

SierraSil is a natural, mineral supplement currently used to improve joint health and function.

PlaceboDIETARY_SUPPLEMENT

Sugar pill manufactured to mimic SierraSil 667 mg capsule

Eligibility

Sex: MALEMin age: 19 YearsMax age: 35 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * no contraindications to strenuous exercise Exclusion Criteria: * muscle or joint injury * taking any form of anti-inflammatory or pain medication * females due to the variability that might be introduced due to the phases of the menstrual cycle

Locations (1)

University of British Columbia

Vancouver, British Columbia, Canada

Outcomes

Primary Outcomes

change in total anaerobic capacity

Time frame: change from baseline at 3 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.